Medistim ASA ( (DE:MD1) ) has shared an announcement.
Medistim ASA has announced its Annual General Meeting scheduled for May 8, 2025, at its Oslo headquarters. The meeting will address various company matters, allowing shareholders to vote via proxy if unable to attend. The announcement includes the release of the 2024 annual report, emphasizing Medistim’s ongoing commitment to transparency and shareholder engagement.
More about Medistim ASA
Medistim ASA, headquartered in Norway, is a niche leader in ultrasound technology, focusing on medical equipment for cardiac, vascular, and transplant surgeries. Established in 1984, the company has shown consistent profitable growth and continues to invest in new product development. Medistim operates through wholly owned subsidiaries in several countries and has a network of about 60 distributors worldwide.
YTD Price Performance: 7.94%
Average Trading Volume: 223
Technical Sentiment Signal: Strong Buy
Current Market Cap: €250.6M
For detailed information about MD1 stock, go to TipRanks’ Stock Analysis page.